The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Cancer-treatment-induced neurotoxicity—focus on newer treatments
Open accessAbstract
Neurotoxicity caused by traditional chemotherapy and radiotherapy is widely recognized in patients with cancer. The adverse effects of newer therapeutics, such as biological and immunotherapeutic agents, are less well established, and are associated with considerable neurotoxicity in the central and peripheral nervous systems. This Review addresses the main neurotoxicities of cancer treatment with a focus on the newer therapeutics. Recognition of these patterns of toxicity is important because drug discontinuation or dose adjustment might prevent further neurological injury. Knowledge of these toxicities also helps to differentiate treatment-related symptoms from progression of cancer or its involvement of the nervous system. Familiarity with the neurological syndromes associated with cancer treatments enables clinicians to use the appropriate treatment for the underlying malignancy while minimizing the risk of neurological damage, which might preserve patients' quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Weber, J. S., Kähler, K. C., & Hauschild, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.6750 · Cited by 1,415
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0914 · Cited by 1,209
Gondi, V., Pugh, S. L., Tome, W. A., Caine, C., Corn, B., Kanner, A., Rowley, H., Kundapur, V., DeNittis, A., Greenspoon, J. N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2909 · Cited by 1,148
Carson, K. R., Evens, A. M., Richey, E. A., Habermann, T. M., Focosi, D., Seymour, J. F., Laubach, J., Bawn, S. D., Gordon, L. I., Winter, J. N., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186999 · Cited by 866
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21204 · Cited by 741
Levin, V. A., Bidaut, L., Hou, P., Kumar, A. J., Wefel, J. S., Bekele, B. N., Prabhu, S., Loghin, M., Gilbert, M. R., & Jackson, E. F. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.061 · Cited by 729
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Maude, S. L., Teachey, D. T., Porter, D. L., & Grupp, S. A. (2015) · Blood · doi:10.1182/blood-2014-12-580068 · Cited by 727
Radiation-induced brain injury: A review
Greene-Schloesser, D., Robbins, M. E., Peiffer, A. M., Shaw, E. G., Wheeler, K. T., & Chan, M. D. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00073 · Cited by 700
Richardson, P. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D. S., Irwin, D., Schuster, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 649
Strandgaard, S., & Paulson, O. B. (1984) · Stroke · doi:10.1161/01.str.15.3.413 · Cited by 597
Bevacizumab plus ipilimumab in patients with metastatic melanoma
Hodi, F. S., Lawrence, D., Lezcano, C., Wu, X., Zhou, J., Sasada, T., Zeng, W., Giobbie-Hurder, A., Atkins, M. B., Ibrahim, N., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0053 · Cited by 593
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.04.012 · Cited by 568
Savvidou, M. D., Hingorani, A. D., Tsikas, D., Frölich, J. C., Vallance, P., & Nicolaides, K. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13177-7 · Cited by 514
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
Lee, J. J., & Swain, S. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0543 · Cited by 472
Tolerability and safety of rituximab (MabThera®)
Kimby, E. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2005.05.007 · Cited by 470
Verstappen, C. C. P., Heimans, J. J., Hoekman, K., & Postma, T. J. (2003) · Drugs · doi:10.2165/00003495-200363150-00003 · Cited by 456
The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
DENICOFF, K. D., RUBINOW, D. R., PAPA, M. Z., SIMPSON, C., SEIPP, C. A., LOTZE, M. T., CHANG, A. E., ROSENSTEIN, D., & ROSENBERG, S. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-293 · Cited by 455
Goldenberg, M. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88288-0 · Cited by 453
Chemotherapy-induced neuropathy: A comprehensive survey
Miltenburg, N. C., & Boogerd, W. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.04.004 · Cited by 431
Neuropsychological effects of cranial radiation: current knowledge and future directions
Roman, D. D., & Sperduto, P. W. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)00550-8 · Cited by 429
Baselga, J., Carbonell, X., Castañeda-Soto, N.-J., Clemens, M., Green, M., Harvey, V., Morales, S., Barton, C., & Ghahramani, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.014 · Cited by 425
Radiation injury and neurogenesis
Monje, M. L., & Palmer, T. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200304000-00002 · Cited by 377
Brachial plexus lesions in patients with cancer=100 cases
Kori, S. H., Foley, K. M., & Posner, J. B. (1981) · Neurology · doi:10.1212/wnl.31.1.45 · Cited by 369
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
(2006) · New England Journal of Medicine · doi:10.1056/nejmc052954 · Cited by 365
Neurologic Complications of Cancer
Wen, P. Y., & Glantz, M. J. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00100-7 · Cited by 361
Chemotherapy-induced peripheral neurotoxicity
Cavaletti, G., & Marmiroli, P. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.160 · Cited by 351
Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy
Dietrich, J., Monje, M., Wefel, J., & Meyers, C. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0130 · Cited by 341
Treatment of radiation‐induced nervous system injury with heparin and warfarin
Glantz, M. J., Burger, P. C., Friedman, A. H., Radtke, R. A., Massey, E. W., & Schold, S. C. (1994) · Neurology · doi:10.1212/wnl.44.11.2020 · Cited by 325
Review article: metoclopramide and tardive dyskinesia
RAO, A. S., & CAMILLERI, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04189.x · Cited by 316
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Christie, L.-A., Acharya, M. M., Parihar, V. K., Nguyen, A., Martirosian, V., & Limoli, C. L. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2000 · Cited by 311
Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma
Liao, B., Shroff, S., Kamiya-Matsuoka, C., & Tummala, S. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou001 · Cited by 288
Cytarabine and neurologic toxicity.
Baker, W. J., Royer, G. L., & Weiss, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.679 · Cited by 285
Diouf, B., Crews, K. R., Lew, G., Pei, D., Cheng, C., Bao, J., Zheng, J. J., Yang, W., Fan, Y., Wheeler, H. E., et al. (2015) · JAMA · doi:10.1001/jama.2015.0894 · Cited by 278
Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., Cortinovis, D., & Bidoli, P. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.008 · Cited by 274
NCCN Task Force Report: Management of Neuropathy in Cancer
Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., Junck, L., Morris, G. S., Paice, J. A., Tummala, S., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0078 · Cited by 257
Sadetzki, S., Chetrit, A., Freedman, L., Stovall, M., Modan, B., & Novikov, I. (2005) · Radiation Research · doi:10.1667/rr3329 · Cited by 257
Central and peripheral nervous system toxicity of common chemotherapeutic agents
Sioka, C., & Kyritsis, A. P. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0876-6 · Cited by 251
Land, S. R., Kopec, J. A., Cecchini, R. S., Ganz, P. A., Wieand, H. S., Colangelo, L. H., Murphy, K., Kuebler, J. P., Seay, T. E., Needles, B. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6652 · Cited by 239
Radiation-induced brachial plexus injury: follow-up of two different fractionation schedules
Powell, S., Cooke, J., & Parsons, C. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90057-4 · Cited by 222
Badros, A., Goloubeva, O., Dalal, J. S., Can, I., Thompson, J., Rapoport, A. P., Heyman, M., Akpek, G., & Fenton, R. G. (2007) · Cancer · doi:10.1002/cncr.22921 · Cited by 217
Posterior reversible encephalopathy syndrome: The endothelial hypotheses
Marra, A., Vargas, M., Striano, P., Del Guercio, L., Buonanno, P., & Servillo, G. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.02.022 · Cited by 215
Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis
Monje, M., & Dietrich, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.012 · Cited by 214
Mileshkin, L., Stark, R., Day, B., Seymour, J. F., Zeldis, J. B., & Prince, H. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6689 · Cited by 211
Persistent neurotoxicity of systemically administered interferon‐alpha
Meyers, C. A., Scheibel, R. S., & Forman, A. D. (1991) · Neurology · doi:10.1212/wnl.41.5.672 · Cited by 208
Long-Term Impact of Radiation on the Stem Cell and Oligodendrocyte Precursors in the Brain
Panagiotakos, G., Alshamy, G., Chan, B., Abrams, R., Greenberg, E., Saxena, A., Bradbury, M., Edgar, M., Gutin, P., & Tabar, V. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000588 · Cited by 185
Central nervous system toxicity of interferon
Rohatiner, A. Z., Prior, P. F., Burton, A. C., Smith, A. T., Balkwill, F. R., & Lister, T. A. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.63 · Cited by 183
Cerebellar toxicity with high-dose cytosine arabinoside.
Herzig, R. H., Hines, J. D., Herzig, G. P., Wolff, S. N., Cassileth, P. A., Lazarus, H. M., Adelstein, D. J., Brown, R. A., Coccia, P. F., & Strandjord, S. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.6.927 · Cited by 162
Effects of Radiation on Cerebral Vasculature: A Review
O'Connor, M. M., & Mayberg, M. R. (2000) · Neurosurgery · doi:10.1093/neurosurgery/46.1.138 · Cited by 160
Neurologic Complications of Cancer and its Treatment
Giglio, P., & Gilbert, M. R. (2010) · Current Oncology Reports · doi:10.1007/s11912-009-0071-x · Cited by 159
Drug-Induced Aseptic Meningitis
Jolles, S. R. A., Sewell, W. A. C., & Leighton, C. (2000) · Drug Safety · doi:10.2165/00002018-200022030-00005 · Cited by 159
Rollins, N. K., Winick, N. J., Bash, R. O., & Booth, T. N. (2004) · PubMed Central · Cited by 158
Dillman, R. O. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006341717398 · Cited by 154
The double-edged sword: Neurotoxicity of chemotherapy
Magge, R., & DeAngelis, L. M. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.012 · Cited by 154
Self-citationSchutz, F. A. B., Je, Y., Azzi, G., Nguyen, P. L., & Choueiri, T. K. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq587 · Cited by 151
Neurotoxic Effects of Cisplatin Therapy
Walsh, T. J., Clark, A. W., Parhad, I. M., & Green, W. R. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510230045013 · Cited by 142
Carson, K. R., Newsome, S. D., Kim, E. J., Wagner‐Johnston, N. D., von Geldern, G., Moskowitz, C. H., Moskowitz, A. J., Rook, A. H., Jalan, P., Loren, A. W., et al. (2014) · Cancer · doi:10.1002/cncr.28712 · Cited by 140
Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
Beijers, A. J. M., Jongen, J. L. M., & Vreugdenhil, G. (2012) · PubMed · Cited by 139
Argyriou, A. A., Chroni, E., Koutras, A. K., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., & Kalofonos, H. P. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0072-3 · Cited by 138
Neurological immune-related adverse events of ipilimumab
Bot, I., Blank, C. U., Boogerd, W. J., & Brandsma, D. (2013) · Practical Neurology · doi:10.1136/practneurol-2012-000447 · Cited by 137
Cranial radiation therapy and damage to hippocampal neurogenesis
Monje, M. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.26 · Cited by 131
Posterior reversible encephalopathy syndrome
Lamy, C., Oppenheim, C., & Mas, J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00109-7 · Cited by 130
Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities
Kwong, Y., Yeung, D. Y. M., & Chan, J. C. W. (2008) · Annals of Hematology · doi:10.1007/s00277-008-0645-y · Cited by 130
Travis, L. B., Fosså, S. D., Sesso, H. D., Frisina, R. D., Herrmann, D. N., Beard, C. J., Feldman, D. R., Pagliaro, L. C., Miller, R. C., Vaughn, D. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju044 · Cited by 123
Thrombosis associated with angiogenesis inhibitors
Elice, F., Rodeghiero, F., Falanga, A., & Rickles, F. R. (2009) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2009.01.001 · Cited by 123
Ziegler, D., & Fonseca, V. A. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.08.008 · Cited by 120
Balasubramaniam, A., Shannon, P. T., Hodaie, M., Laperrière, N., Michaels, H. B., & Guha, A. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-027 · Cited by 116
Jaeckle, K. A., Batchelor, T. T., O'Day, S. J., Phuphanich, S., New, P., Lesser, G. J., Cohn, A. L., Gilbert, M. R., Aiken, R. D., Heros, D. O., et al. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015752331041 · Cited by 113
A phase-2 trial of low-dose pomalidomide in myelofibrosis
Begna, K. H., Mesa, R. A., Pardanani, A. D., Hogan, W. J., Litzow, M. R., McClure, R. F., & Tefferi, A. (2010) · Leukemia · doi:10.1038/leu.2010.254 · Cited by 112
Lee, Y. W., Cho, H. J., Lee, W. H., & Sonntag, W. E. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.4.357 · Cited by 112
Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
Davila, M. L., Bouhassira, D. C. G., Park, J. H., Curran, K. J., Smith, E. L., Pegram, H. J., & Brentjens, R. J. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1479-5 · Cited by 111
Chemotherapy-Induced Neuropathy
Cavaletti, G., Alberti, P., Frigeni, B., Piatti, M., & Susani, E. L. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0108-3 · Cited by 110
Waber, D. P., Turek, J., Catania, L., Stevenson, K. E., Robaey, P., Romero, I., Adams, H., Alyman, C., Jandet‐Brunet, C., Neuberg, D. S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8464 · Cited by 110
Whole Brain Radiation-Induced Vascular Cognitive Impairment: Mechanisms and Implications
Warrington, J. P., Ashpole, N. M., Csiszár, A., Lee, Y. W., Ungvari, Z. I., & Sonntag, W. E. (2013) · Journal of Vascular Research · doi:10.1159/000354227 · Cited by 100
Neurologic complications of cancer therapy
Plotkin, S. R., & Wen, P. Y. (2003) · Neurologic Clinics · doi:10.1016/s0733-8619(02)00034-8 · Cited by 94
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer
Biesma, B., Willemse, P., Mulder, N., Sleijfer, D. T., Gietema, J. A., Mull, R., Limburg, P. C., Bouma, J. M., Vellenga, E., & de Vries, E. G. E. (1992) · Blood · doi:10.1182/blood.v80.5.1141.1141 · Cited by 89
Diffusion-Weighted MRI Correlates of Subacute Methotrexate-Related Neurotoxicity
Haykin, M., Gorman, M., van Hoff, J., Fulbright, R. K., & Baehring, J. M. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-4569-2 · Cited by 82
Chen, J., Dassarath, M., Yin, Z., et al. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-128 · Cited by 81
Radiation Necrosis: Relevance with Respect to Treatment of Primary and Secondary Brain Tumors
Fink, J. R., Born, D. E., & Chamberlain, M. C. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0258-7 · Cited by 77
Gamma Knife surgery–induced meningioma
Sheehan, J. P., Yen, C. P., & Steiner, L. E. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.105.2.325 · Cited by 75
Neurologic Complications of Cancer Chemotherapy
Sul, J., & DeAngelis, L. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.03.006 · Cited by 75
Self-citationNeurologic complications of chemotherapy and other newer and experimental approaches
Soffietti, R., Trevisan, E., & Rudà, R. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00080-8 · Cited by 69
Myers, J. S. (2009) · Clinical journal of oncology nursing · doi:10.1188/09.cjon.413-421 · Cited by 66
Neurotoxicity of Cancer Chemotherapy
Dropcho, E. J. (2004) · Seminars in Neurology · doi:10.1055/s-2004-861536 · Cited by 59
Glutamine: A novel approach to chemotherapy-induced toxicity
Kumar, G., Goel, R. K., Shukla, M., & Pandey, M. (2012) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.96962 · Cited by 55
Diffusion tensor imaging of hippocampal network plasticity
Sierra, A., Laitinen, T., Gröhn, O. H. J., & Pitkänen, A. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0683-7 · Cited by 55
Isidoro, L., Pires, P., Rito, L., & Cordeiro, G. (2014) · BMJ Case Reports · doi:10.1136/bcr-2013-201781 · Cited by 55
Oral Glutamine for the Prevention of Chemotherapy-Induced Peripheral Neuropathy
Amara, S. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l179 · Cited by 49
Cerebellar toxicity following high-dose cytosine arabinoside.
Dworkin, L. A., Goldman, R. D., Zivin, L. S., & Fuchs, P. C. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.5.613 · Cited by 47
Early and Late Long-Term Effects of Adjuvant Chemotherapy
Mayer, E. L. (2013) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbook_am.2013.33.9 · Cited by 39
Ryan, J. (2000) · Journal of Pediatric Oncology Nursing · doi:10.1177/104345420001700107 · Cited by 34
Pfeiffer, P., Nielsen, D. L., Yilmaz, M., Iversen, A., Vejlø, C., & Jensen, B. V. (2007) · Acta Oncologica · doi:10.1080/02841860601009455 · Cited by 34
Dropped head syndrome: Report of three cases during treatment with a MEK inhibitor
Chen, X., Schwartz, G. K., DeAngelis, L. M., Kaley, T. J., & Carvajal, R. D. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f87e · Cited by 32
Self-citationNeurotoxicity of Cancer Chemotherapy
Dropcho, E. J. (2010) · Seminars in Neurology · doi:10.1055/s-0030-1255217 · Cited by 30
Gabapentin Prevents Oxaliplatin-Induced Mechanical Hyperalgesia in Mice
Ohsawa, M., Otake, S., Murakami, T., Yamamoto, S., Makino, T., & Ono, H. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14058fp · Cited by 29
The Possible Role of Cytokines in Chemotherapy-Induced Cognitive Deficits
Myers, J. S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6306-2_15 · Cited by 27
Chen, W., Wang, F., & Xu, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068974 · Cited by 24
Bevacizumab-related toxicities in the National Cancer Institute malignant glioma trial cohort
Odia, Y., Shih, J. H., Kreisl, T. N., & Fine, H. A. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1571-6 · Cited by 24
Thalidomide and lenalidomide in multiple myeloma
Mazumder, A., & Jagannath, S. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.06.006 · Cited by 23
Therapy for Chemotherapy-Induced Peripheral Neuropathy
Seretny, M., Colvin, L., & Fallon, M. (2013) · JAMA · doi:10.1001/jama.2013.7902 · Cited by 9
Cited by
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
The mutational footprints of cancer therapies
Pich, O., Muiños, F., Lolkema, M. P., Steeghs, N., Gonzalez-Perez, A., & Lopez-Bigas, N. (2019) · Nature Genetics · doi:10.1038/s41588-019-0525-5 · Cited by 309
Khalighi, S., Reddy, K., Midya, A., Pandav, K. B., Madabhushi, A., & Abedalthagafi, M. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00575-0 · Cited by 306
Mechanisms of Chemotherapy-Induced Neurotoxicity
Was, H., Borkowska, A., Bagues, A., Tu, L., Liu, J. Y. H., Lu, Z., Rudd, J. A., Nurgali, K., & Abalo, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750507 · Cited by 285
Active DNA demethylation promotes cell fate specification and the DNA damage response
Wang, D., Wu, W., Callen, E., Pavani, R., Zolnerowich, N., Kodali, S., Zong, D., Wong, N., Noriega, S., Nathan, W. J., et al. (2022) · Science · doi:10.1126/science.add9838 · Cited by 113
Metadata
- Authors
- Stone, J. B., & DeAngelis, L. M.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2015-09-22
- Volume
- 13
- Issue
- 2
- Pages
- 92-105
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2265953833
- Cited by
- 274
- References
- 105
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.